157 related articles for article (PubMed ID: 8886186)
1. Impact of human recombinant erythropoietin on plasminogen activator inhibitor, and protein C and S activity.
Steffensen G; Aunsholt NA
Am J Nephrol; 1996; 16(5):453-4. PubMed ID: 8886186
[No Abstract] [Full Text] [Related]
2. Erythropoietin escape in five CAPD patients.
Williams P; Jones J
Nephron; 1996; 73(2):354. PubMed ID: 8773387
[No Abstract] [Full Text] [Related]
3. Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation.
Jaar B; Denis A; Viron B; Verdy E; Chamma F; Siohan P; Mignon F
Am J Nephrol; 1997; 17(5):399-405. PubMed ID: 9382155
[TBL] [Abstract][Full Text] [Related]
4. Treatment of renal anemia with recombinant human erythropoietin.
Schaefer RM; Hörl WH; Massry SG
Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
[No Abstract] [Full Text] [Related]
5. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
Macdougall IC; Cavill I; Davies ME; Hutton RD; Coles GA; Williams JD
Contrib Nephrol; 1989; 76():219-26. PubMed ID: 2582780
[No Abstract] [Full Text] [Related]
6. Recombinant human erythropoietin and peritoneal dialysis.
Digenis GE; Yatzidis H
Int J Artif Organs; 1990 Jun; 13(6):344-6. PubMed ID: 2199378
[No Abstract] [Full Text] [Related]
7. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
[TBL] [Abstract][Full Text] [Related]
8. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM
Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
[No Abstract] [Full Text] [Related]
9. Subcutaneous erythropoietin in the treatment of renal anaemia.
Drinovec J; Varl J
Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
[TBL] [Abstract][Full Text] [Related]
10. Increased ultrafiltration after erythropoietin-induced correction of renal anemia in patients on continuous ambulatory peritoneal dialysis.
Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Hörl WH; Schollmeyer P
Nephron; 1989; 53(1):91-2. PubMed ID: 2779711
[No Abstract] [Full Text] [Related]
11. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
12. Recombinant human erythropoietin in patients on peritoneal dialysis.
Bargman J
Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
[No Abstract] [Full Text] [Related]
13. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
[No Abstract] [Full Text] [Related]
14. [Therapy of renal anemia with recombinant human erythropoietin].
Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
[TBL] [Abstract][Full Text] [Related]
15. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
16. Effects of withdrawing erythropoietin.
Taylor JE; Henderson IS; Mactier RA; Stewart WK
BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
[No Abstract] [Full Text] [Related]
17. Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD.
Hughes RT; Cotes PM; Oliver DO; Pippard MJ; Royston P; Stevens JM; Strong CA; Tam RC; Winearls CG
Contrib Nephrol; 1989; 76():122-30. PubMed ID: 2582777
[No Abstract] [Full Text] [Related]
18. Serum immunoreactive erythropoietin in patients with end stage renal disease.
Gimenez LF; Watson AJ; Spivak JL
Prog Clin Biol Res; 1990; 352():493-504. PubMed ID: 2402519
[No Abstract] [Full Text] [Related]
19. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
20. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
Marsden JT; Sherwood RA; Hillis A; Peters TJ
Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
